Marikunte V. Venkataranganna
Research Subjects
Research Interests
Marikunte V. Venkataranganna has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
S. Gopumadhavan
R & D Centre, The Himalaya Drug Co., Makali, Bangalore ‐ 562 123, India
3 shared publicationsR Sundaram
2 shared publicationsS Gopumadhavan
2 shared publicationsS.K Mitra
R&D Centre, The Himalaya Drug Company, Makali, Bangalore, India
2 shared publications- Suryakanth Dattatraya Anturlikar
Department of Pharmacology, R&D Center, The Himalaya Drug Company, Bangalore, India
2 shared publications U. Venkatesha Udupa
R & D Centre, The Himalaya Drug Co., Makali, Bangalore ‐ 562 123, India
2 shared publications
Latest Publications
- 30 July 2001
- Published by Wiley in Phytotherapy Research
- Vol. 15 (6) , 493-496
The protective effect of HD‐03 in CCl4‐induced hepatic encephalopathy in rats
The liver is a major parenchymal organ involved in many functional activities in the body. Hepatic encephalopathy is a syndrome characterized by increased blood ammonia level and is one of the major complications of cirrhosis. In the present study the protective effect of HD‐03, a poly‐herbal formulation, was evaluated against CCl4‐induced hepatic encephalopathy in rats. Hepatic encephalopathy was induced in Wistar rats by administration of CCl4 at a dose of 1 mL/kg orally in liquid paraffin (1:1) twice a week for 90 days. The liver enzymes (SGPT and SGOT) and blood ammonia levels were significantly (p < 0.001) higher in the CCl4‐intoxicated group compared with the untreated control group. Administration of HD‐03 at a dose of 750 mg/kg orally as an aqueous suspension significantly prevented the elevation of SGPT, SGOT and blood ammonia levels. Histomorphometric evaluation of liver and brain showed a protective effect of the HD‐03 treatment, thus correlating with the changes in biochemical profiles. The protective effect of HD‐03 against CCl4‐induced encephalopathy may be due to the improved hepatocellular function, which in turn helps in regulating the metabolism of ammonia. However, further studies are required to measure the activity of enzymes involved in the urea cycle and brain aromatic amino acids in order to elucidate the exact mechanism of action of HD‐03. Copyright © 2001 John Wiley & Sons, Ltd.
- 30 July 2001
- Published by Wiley in Phytotherapy Research
- Vol. 15 (6) , 493-496
The protective effect of HD‐03 in CCl4‐induced hepatic encephalopathy in rats
The liver is a major parenchymal organ involved in many functional activities in the body. Hepatic encephalopathy is a syndrome characterized by increased blood ammonia level and is one of the major complications of cirrhosis. In the present study the protective effect of HD‐03, a poly‐herbal formulation, was evaluated against CCl4‐induced hepatic encephalopathy in rats. Hepatic encephalopathy was induced in Wistar rats by administration of CCl4 at a dose of 1 mL/kg orally in liquid paraffin (1:1) twice a week for 90 days. The liver enzymes (SGPT and SGOT) and blood ammonia levels were significantly (p < 0.001) higher in the CCl4‐intoxicated group compared with the untreated control group. Administration of HD‐03 at a dose of 750 mg/kg orally as an aqueous suspension significantly prevented the elevation of SGPT, SGOT and blood ammonia levels. Histomorphometric evaluation of liver and brain showed a protective effect of the HD‐03 treatment, thus correlating with the changes in biochemical profiles. The protective effect of HD‐03 against CCl4‐induced encephalopathy may be due to the improved hepatocellular function, which in turn helps in regulating the metabolism of ammonia. However, further studies are required to measure the activity of enzymes involved in the urea cycle and brain aromatic amino acids in order to elucidate the exact mechanism of action of HD‐03. Copyright © 2001 John Wiley & Sons, Ltd.
- 1 January 2001
- Published by Elsevier in Phytomedicine
- Vol. 8 (3) , 195-201
The beneficial effect of OST-6 (OsteoCare), a herbomineral formulation, in experimental osteoporosis
- 1 January 2001
- Published by Elsevier in Phytomedicine
- Vol. 8 (3) , 195-201
The beneficial effect of OST-6 (OsteoCare), a herbomineral formulation, in experimental osteoporosis
- 1 December 1998
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 63 (3) , 181-186
Protective effect of HD-03, a herbal formulation, against various hepatotoxic agents in rats
- 1 December 1998
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 63 (3) , 181-186
Protective effect of HD-03, a herbal formulation, against various hepatotoxic agents in rats
- 1 December 1998
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 63 (3) , 187-192
Evaluation of possible mechanism of anti-ulcerogenic activity of UL-409, a herbal preparation
- 1 December 1998
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 63 (3) , 187-192
Evaluation of possible mechanism of anti-ulcerogenic activity of UL-409, a herbal preparation
- 1 July 1996
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 52 (3) , 165-169
Protective effect of UL-409, a herbal formulation against physical and chemical factor induced gastric and duodenal ulcers in experimental animals
- 1 July 1996
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 52 (3) , 165-169
Protective effect of UL-409, a herbal formulation against physical and chemical factor induced gastric and duodenal ulcers in experimental animals